Tiziana Life Sciences
Tiziana Life Sciences is developing its monoclonal antibody named TZLS-501 for the treatment of COVID-19.
Rankings by 
Национальный рейтинг
50th
in United KingdomРегиональный рейтинг
265th
in Western EuropeГлобальный рейтинг
1146th
worldwide